Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Amphotericin B | Case report

Pulmonary Cryptococcus infections as a manifestation of idiopathic CD4 lymphocytopenia: case report and literature review

Authors: Christina S. Thornton, Oscar Larios, Jennifer Grossman, Thomas P. Griener, Steven Vaughan

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Idiopathic CD4 lymphocytopenia (ICL) is a rare clinical disease with relative CD4 deficiency in the absence of HIV infection. The pathogenicity of ICL is poorly understood with an unclear incidence rate in the general population. Sequelae of ICL includes AIDS-defining infections, which most commonly includes Cryptococcus neoformans. Typically, C. neoformans infections present with CNS involvement but rarely with extra-CNS manifestations. Here, we present a rare case of ICL with exclusively primary pulmonary cryptococcus and a review of the literature.

Case presentation

A 56-year-old female presented to our tertiary care hospital requiring a right hip open reduction intervention. The patient became febrile during admission, prompting a work-up that included a chest X-ray showing a peripheral pulmonary solitary nodule. Transthoracic biopsy revealed encapsulated yeast forms in keeping with C. neoformans. CD4 counts, repeated at least one month apart, were < 200 cells/mm3, with negative HIV testing. Flow cytometry and genetic testing were completed to elucidate the etiology of the immune deficiency, both of which were unremarkable. She was subsequently treated with 12 months of posaconazole with clinical resolution.

Conclusions

Our patient highlights a rare clinical disease, which a review of literature revealed only five cases in the literature with exclusive pulmonary Cryptococcus in ICL/ This case demonstrates the strong clinical acumen required to properly diagnose and ultimately manage the patient.
Literature
1.
go back to reference Yarmohammadi H, Cunningham-Rundles C. Idiopathic CD4 lymphocytopenia: Pathogenesis, etiologies, clinical presentations and treatment strategies. Ann Allergy Asthma Immunol. 2017;119(4):374–8.CrossRef Yarmohammadi H, Cunningham-Rundles C. Idiopathic CD4 lymphocytopenia: Pathogenesis, etiologies, clinical presentations and treatment strategies. Ann Allergy Asthma Immunol. 2017;119(4):374–8.CrossRef
2.
go back to reference Centers for Disease C. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection--United States. MMWR Morb Mortal Wkly Rep. 1992;41(30):541–5. Centers for Disease C. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection--United States. MMWR Morb Mortal Wkly Rep. 1992;41(30):541–5.
3.
go back to reference Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291–322.CrossRef Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291–322.CrossRef
4.
go back to reference McMullan BJ, Halliday C, Sorrell TC, Judd D, Sleiman S, Marriott D, Olma T, Chen SC. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One. 2012;7(11):e49541.CrossRef McMullan BJ, Halliday C, Sorrell TC, Judd D, Sleiman S, Marriott D, Olma T, Chen SC. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One. 2012;7(11):e49541.CrossRef
5.
go back to reference Ahmad DS, Esmadi M, Steinmann WC. Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med. 2013;3(2):37–47.CrossRef Ahmad DS, Esmadi M, Steinmann WC. Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med. 2013;3(2):37–47.CrossRef
6.
go back to reference Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, Centers for Disease C, Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep. 2008;57(RR-10):1–12.PubMed Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, Centers for Disease C, Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep. 2008;57(RR-10):1–12.PubMed
7.
go back to reference Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The centers for disease control idiopathic CD4+ T-lymphocytopenia task force. N Engl J Med. 1993;328(6):373–9.CrossRef Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The centers for disease control idiopathic CD4+ T-lymphocytopenia task force. N Engl J Med. 1993;328(6):373–9.CrossRef
8.
go back to reference Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SB, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287–94.CrossRef Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SB, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287–94.CrossRef
9.
go back to reference Nehme NT, Schmid JP, Debeurme F, Andre-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood. 2012;119(15):3458–68.CrossRef Nehme NT, Schmid JP, Debeurme F, Andre-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood. 2012;119(15):3458–68.CrossRef
10.
go back to reference Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, van Lier RA, van der Burg M. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117(22):5892–6.CrossRef Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, van Lier RA, van der Burg M. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117(22):5892–6.CrossRef
11.
go back to reference Lin SJ, Chao HC, Yan DC, Kuo ML. Idiopathic CD4+ T lymphocytopenia in two siblings. Pediatr Hematol Oncol. 2001;18(2):153–6.CrossRef Lin SJ, Chao HC, Yan DC, Kuo ML. Idiopathic CD4+ T lymphocytopenia in two siblings. Pediatr Hematol Oncol. 2001;18(2):153–6.CrossRef
12.
go back to reference Freier S, Kerem E, Dranitzki Z, Schlesinger M, Rabinowitz R, Brautbar C, Ashkirat M, Naparstek Y. Hereditary CD4+ T lymphocytopenia. Arch Dis Child. 1998;78(4):371–2.CrossRef Freier S, Kerem E, Dranitzki Z, Schlesinger M, Rabinowitz R, Brautbar C, Ashkirat M, Naparstek Y. Hereditary CD4+ T lymphocytopenia. Arch Dis Child. 1998;78(4):371–2.CrossRef
13.
go back to reference Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT, Investigators H. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010;24(10):1549–59.CrossRef Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, Wood KC, Brooks JT, Investigators H. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010;24(10):1549–59.CrossRef
14.
go back to reference Sone K, Muramatsu H, Nakao M, Kagawa Y, Kurokawa R, Sato H, Niimi A. Pneumocystis pneumonia secondary to idiopathic CD4+ T-lymphocytopenia: a comparison of AIDS and non-AIDS patients. Intern Med. 2018;57(3):383–6.CrossRef Sone K, Muramatsu H, Nakao M, Kagawa Y, Kurokawa R, Sato H, Niimi A. Pneumocystis pneumonia secondary to idiopathic CD4+ T-lymphocytopenia: a comparison of AIDS and non-AIDS patients. Intern Med. 2018;57(3):383–6.CrossRef
15.
go back to reference Said S, Alkhateeb H, Cooper CJ, Rodriguez E, Trien R, Hernandez GT, Salameh HS. Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review. Int Med Case Rep J. 2014;7:117–20.CrossRef Said S, Alkhateeb H, Cooper CJ, Rodriguez E, Trien R, Hernandez GT, Salameh HS. Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review. Int Med Case Rep J. 2014;7:117–20.CrossRef
16.
go back to reference Menon BS, Shuaib IL, Zamari M, Haq JA, Aiyar S, Noh LM. Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis. Ann Trop Paediatr. 1998;18(1):45–8.CrossRef Menon BS, Shuaib IL, Zamari M, Haq JA, Aiyar S, Noh LM. Idiopathic CD4+ T-lymphocytopenia in a child with disseminated cryptococcosis. Ann Trop Paediatr. 1998;18(1):45–8.CrossRef
17.
go back to reference Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore). 2007;86(2):78–92.CrossRef Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore). 2007;86(2):78–92.CrossRef
18.
go back to reference Kumlin U, Elmqvist LG, Granlund M, Olsen B, Tarnvik A. CD4 lymphopenia in a patient with cryptococcal osteomyelitis. Scand J Infect Dis. 1997;29(2):205–6.CrossRef Kumlin U, Elmqvist LG, Granlund M, Olsen B, Tarnvik A. CD4 lymphopenia in a patient with cryptococcal osteomyelitis. Scand J Infect Dis. 1997;29(2):205–6.CrossRef
19.
go back to reference Zanelli G, Sansoni A, Ricciardi B, Ciacci C, Cellesi C. Muscular-skeletal cryptococcosis in a patient with idiopathic CD4+ lymphopenia. Mycopathologia. 2001;149(3):137–9.CrossRef Zanelli G, Sansoni A, Ricciardi B, Ciacci C, Cellesi C. Muscular-skeletal cryptococcosis in a patient with idiopathic CD4+ lymphopenia. Mycopathologia. 2001;149(3):137–9.CrossRef
20.
go back to reference Regent A, Autran B, Carcelain G, Cheynier R, Terrier B, Charmeteau-De Muylder B, Krivitzky A, Oksenhendler E, Costedoat-Chalumeau N, Hubert P, et al. Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients. Medicine (Baltimore). 2014;93(2):61–72.CrossRef Regent A, Autran B, Carcelain G, Cheynier R, Terrier B, Charmeteau-De Muylder B, Krivitzky A, Oksenhendler E, Costedoat-Chalumeau N, Hubert P, et al. Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients. Medicine (Baltimore). 2014;93(2):61–72.CrossRef
21.
go back to reference Nunez MJ, de Lis JM, Rodriguez JR, Allegue MJ, Viladrich A, Conde C, Santiago MP, Amigo MC. disseminated encephalic cryptococcosis as a form of presentation of idiopathic T-CD4 lymphocytopenia. Rev Neurol. 1999;28(4):390–3.PubMed Nunez MJ, de Lis JM, Rodriguez JR, Allegue MJ, Viladrich A, Conde C, Santiago MP, Amigo MC. disseminated encephalic cryptococcosis as a form of presentation of idiopathic T-CD4 lymphocytopenia. Rev Neurol. 1999;28(4):390–3.PubMed
22.
go back to reference Ahn IS, Kim HG, Ryu JS, Kim L, Kwak SM, Lee HL, Yoon YH, Cho JH. A case of pulmonary cryptococcosis with non-small cell lung cancer in idiopathic CD4+ T-lymphocytopenia. Yonsei Med J. 2005;46(1):173–6.CrossRef Ahn IS, Kim HG, Ryu JS, Kim L, Kwak SM, Lee HL, Yoon YH, Cho JH. A case of pulmonary cryptococcosis with non-small cell lung cancer in idiopathic CD4+ T-lymphocytopenia. Yonsei Med J. 2005;46(1):173–6.CrossRef
23.
go back to reference Lin JC, Tripathi HM. Pure red cell aplasia and idiopathic CD4 T-lymphocytopenia. Clin Infect Dis. 1994;18(4):651–2.CrossRef Lin JC, Tripathi HM. Pure red cell aplasia and idiopathic CD4 T-lymphocytopenia. Clin Infect Dis. 1994;18(4):651–2.CrossRef
24.
go back to reference McNulty A, Kaldor JM, McDonald AM, Baumgart K, Cooper DA. Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ. 1994;308(6932):825–6.CrossRef McNulty A, Kaldor JM, McDonald AM, Baumgart K, Cooper DA. Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ. 1994;308(6932):825–6.CrossRef
25.
go back to reference Zaharatos GJ, Behr MA, Libman MD. Profound T-lymphocytopenia and cryptococcemia in a human immunodeficiency virus-seronegative patient with disseminated tuberculosis. Clin Infect Dis. 2001;33(11):E125–8.CrossRef Zaharatos GJ, Behr MA, Libman MD. Profound T-lymphocytopenia and cryptococcemia in a human immunodeficiency virus-seronegative patient with disseminated tuberculosis. Clin Infect Dis. 2001;33(11):E125–8.CrossRef
26.
go back to reference Yuanjie Z, Julin G, Fubing C, Jianghan C. Recurrent pulmonary cryptococcosis in a patient with idiopathic CD4 lymphocytopenia. Med Mycol. 2008;46(7):729–34.CrossRef Yuanjie Z, Julin G, Fubing C, Jianghan C. Recurrent pulmonary cryptococcosis in a patient with idiopathic CD4 lymphocytopenia. Med Mycol. 2008;46(7):729–34.CrossRef
Metadata
Title
Pulmonary Cryptococcus infections as a manifestation of idiopathic CD4 lymphocytopenia: case report and literature review
Authors
Christina S. Thornton
Oscar Larios
Jennifer Grossman
Thomas P. Griener
Steven Vaughan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4453-x

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine